Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial

2021 ◽  
Author(s):  
Marijn Lijffijt ◽  
Nicholas Murphy ◽  
Sidra Iqbal ◽  
Charles E. Green ◽  
Tabish Iqbal ◽  
...  
Keyword(s):  
Late Life ◽  
Optimal Dose ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Adaptive Randomization ◽  
Resistant Depression ◽  
Intravenous Ketamine

scholarly journals Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study

2018 ◽  
Vol 28 (7) ◽  
pp. 437-444 ◽  
Author(s):  
Kathryn R. Cullen ◽  
Palistha Amatya ◽  
Mark G. Roback ◽  
Christina Sophia Albott ◽  
Melinda Westlund Schreiner ◽  
...  
Keyword(s):  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Resistant Depression ◽  
Intravenous Ketamine

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

2021 ◽  
pp. appi.ajp.2020.2
Author(s):  
Jennifer B. Dwyer ◽  
Angeli Landeros-Weisenberger ◽  
Jessica A. Johnson ◽  
Amalia Londono Tobon ◽  
José M. Flores ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Adolescent Treatment ◽  
Resistant Depression ◽  
Intravenous Ketamine
Sign in / Sign up

Export Citation Format

Share Document